Monocytic cell necrosis is mediated by potassium depletion and caspase-like proteasesWARNY, M; KELLY, C. P.American journal of physiology. Cell physiology. 1999, Vol 45, Num 3, pp C717-C724, issn 0363-6143Article

Clostridium difficile colitis : recent therapeutical and immunological considerationsDELMEE, M; WARNY, M.Acta gastro-enterologica belgica (Ed. multilingue). 1995, Vol 58, Num 3-4, pp 313-317, issn 0001-5644Conference Paper

The anti-Hu syndrome : a clinical and immunological study of 7 casesPIERET, F; SINDIC, C. J. M; PEETERS, A et al.Acta neurologica belgica. 1996, Vol 96, Num 2, pp 108-116, issn 0300-9009Conference Paper

Virulent Toxoplasma gondii strain RH promotes T-cell-independent overproduction of proinflammatory cytokines IL12 and γ-interferonNGUYEN, T. D; BIGAIGNON, G; VAN SNICK, J et al.Journal of medical microbiology. 2003, Vol 52, Num 10, pp 869-876, issn 0022-2615, 8 p.Article

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin AKYNE, L; WARNY, M; QAMAR, A et al.The New England journal of medicine. 2000, Vol 342, Num 6, pp 390-397, issn 0028-4793Article

IL-8 release and neutrophil activation by Clostridium difficile toxin-exposed human monocytesLINEVSKY, J. K; POTHOULAKIS, C; KEATES, S et al.American journal of physiology. Gastrointestinal and liver physiology. 1997, Vol 36, Num 6, pp G1333-G1340, issn 0193-1857Article

Toxinotype V Clostridium difficile in humans and food animals = Clostridium difficile toxinotype V chez animaux et humainsJHUNG, M.A; THOMPSON, A.D; KILLGORE, G.E et al.EMERGING INFECTIOUS DISEASES. 2008, Vol 14, Num 7, pp 1039-1045, issn 1080-6040, 7 p.Article

Anti-neutrophil antibodies in chronic hepatitis and the effect of α-interferon therapyWARNY, M; BRENARD, R; CORNU, C et al.Journal of hepatology. 1993, Vol 17, Num 3, pp 294-300, issn 0168-8278Article

Clostridium difficile toxin A causes early damage to mitochondria in cultured cellsHE, D; HAGEN, S. J; POTHOULAKIS, C et al.Gastroenterology (New York, NY. 1943). 2000, Vol 119, Num 1, pp 139-150, issn 0016-5085Article

Bovine immunoglobulin concentrate-Clostridium difficile retains C difficile toxin neutralising activity after passage through the human stomach and small intestineWARNY, M; FATIMI, A; BOSTWICK, E. F et al.Gut. 1999, Vol 44, Num 2, pp 212-217, issn 0017-5749Article

Intravenous immunoglobulin therapy for severe Clostridium difficile colitisSALCEDO, J; KEATES, S; POTHOULAKIS, C et al.Gut. 1997, Vol 41, Num 3, pp 366-370, issn 0017-5749Article

Gamma globulin administration in relapsing Clostridium difficile-induced pseudomembranous colitis with a defective antibody response to toxin AWARNY, M; DENIE, C; DELMEE, M et al.Acta Clinica Belgica. 1995, Vol 50, Num 1, pp 36-39, issn 0001-5512Conference Paper

Human antibody response to Clostridium difficile toxin A in relation to clinical course of infectionWARNY, M; VAERMAN, J.-P; AVESANI, V et al.Infection and immunity. 1994, Vol 62, Num 2, pp 384-389, issn 0019-9567Article